Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanfujiu for Persistent Allergic Rhinitis (SPAR Study)
NCT02192645Phase 3Unknown
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Jul 2014
- Primary completion
- Jul 2017
- Modality
- Transdermal Patches
- Countries
- 1
01
Overview
A Phase 3 trial of Sanfujiu in persistent allergic rhinitis (PAR), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Status: unknown.
02
Drugs
Sanfujiu
03
Conditions
persistent allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT02192645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02192645.